The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Open accessAbstract
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [5]
In the citing paper
“Study of Zhou et al.4 indicated that the angiotensin-converting enzyme II (ACE2) is likely the cell receptor of 2019-nCoV, which were also the receptor for SARS-CoV and HCoV-NL637,8.”
From High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (2020) · cites this paper as [7]
In the citing paper
“The cell surface receptor for the CoV-1 and CoV-2 surface spike protein has been identified by affinity-MS to be angiotensin-converting enzyme 2 (ACE2)147”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [147]
In the citing paper
“As an alternative approach, cellular interaction partners for a single viral protein of interest have also been investigated by in vitro incubation of the viral protein bait with lysates from uninfected permissive cells.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“while promoted upon ACE2 overexpression in HEK293T cells that are otherwise non-permissive to SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“which was further functionally characterized as a functional receptor for SARS-CoV.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“MS analysis revealed the cellular metallopeptidase angiotensin-converting enzyme 2 (ACE2) as an S1 interaction partner”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“Viral replication was inhibited upon incubation with antibodies against ACE2”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [59]
In the citing paper
“This interaction requires cleavage of the S protein, likely by the cell surface protease TMPRSS2, although other proteases (such as Cathepsin B and L, CTSB/CTSL) may also be involved (4-6, 22-25).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“CoV-2 — like SARS-CoV — infects cells through interactions between its spike (S) protein and the ACE2 protein on target cells.”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [23]
In the citing paper
“ACE2 is the functional entry receptor for both severe acute respiratory syndrome (SARS) coronaviruses, SARS-CoV (36) and SARS-CoV-2 (37).”
From TCRD and pharos 2021: mining the human proteome for disease biology (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N. J., Rollins, B. J., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G. J., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,286
Self-citationA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
Cited by
Sorted by citations
Items 501–600 of 1,026
Evidence for SARS-CoV-2 Infection of Animal Hosts
Abdel-Moneim, A. S., & Abdelwhab, E. M. (2020) · Pathogens · doi:10.3390/pathogens9070529 · Cited by 209
Honda‐Okubo, Y., Barnard, D. L., Ong, C. H., Peng, B., Tseng, C.-T. K., & Petrovsky, N. (2014) · Journal of Virology · doi:10.1128/jvi.02980-14 · Cited by 208
Reguera, J., Santiago, C. A., Mudgal, G., Ordoño, D., Enjuanes, L., & Casasnovas, J. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002859 · Cited by 208
In Silico Discovery of Candidate Drugs against Covid-19
Cava, C., Bertoli, G. R., & Castiglioni, I. (2020) · Viruses · doi:10.3390/v12040404 · Cited by 208
Will children reveal their secret? The coronavirus dilemma
Cristiani, L., Mancino, E., Matera, L., Nenna, R., Pierangeli, A., Scagnolari, C., & Midulla, F. (2020) · European Respiratory Journal · doi:10.1183/13993003.00749-2020 · Cited by 208
Stebbing, J., Nievas, G. S., Falcone, M., Youhanna, S. C., Richardson, P. J., Ottaviani, S., Shen, J. X., Sommerauer, C., Tiseo, G., Ghiadoni, L., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe4724 · Cited by 208
Self-citationType I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
Mazewski, C., Perez, R. E., Fish, E. N., & Platanias, L. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606456 · Cited by 209
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
Starr, T. N., Zepeda, S. K., Walls, A. C., Greaney, A. J., Alkhovsky, S. V., Veesler, D., & Bloom, J. D. (2022) · Nature · doi:10.1038/s41586-022-04464-z · Cited by 207
Hsieh, P.-K., Chang, S. C., Huang, C.-C., Lee, T.-T., Hsiao, C.-W., Kou, Y.-H., Chen, I.-Y., Chang, C., Huang, T.-H., & Chang, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13848-13855.2005 · Cited by 206
Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
Imai, Y., Kuba, K., Ohto‐Nakanishi, T., & Penninger, J. M. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0045 · Cited by 206
A model of the ACE2 structure and function as a SARS-CoV receptor
Prabakaran, P., Xiao, X., & Dimitrov, D. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.081 · Cited by 206
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
Gramberg, T., Hofmann, H., Möller, P., Lalor, P. F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F., Adams, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.06.026 · Cited by 206
Shen, Q., Xiao, X., Aierken, A., Yue, W., Wu, X., Liao, M., & Hua, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15541 · Cited by 206
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
Lee, S., Channappanavar, R., & Kanneganti, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.005 · Cited by 206
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
Gupte, M., Boustany, C., Bharadwaj, K. G., Police, S. B., Thatcher, S. E., Gong, M. C., English, V. L., & Cassis, L. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00183.2008 · Cited by 204
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Gao, Y.-M., Xu, G., Wang, B., & Liu, B. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13144 · Cited by 204
Saikatendu, K. S., Joseph, J. S., Subramanian, V., Clayton, T., Griffith, M. T., Moy, K., Velasquez, J., Neuman, B. W., Buchmeier, M. J., Stevens, R. C., et al. (2005) · Structure · doi:10.1016/j.str.2005.07.022 · Cited by 203
Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
Kuba, K., Imai, Y., & Penninger, J. M. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1544 · Cited by 201
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 201
Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor
Peng, G., Sun, D., Rajashankar, K. R., Qian, Z., Holmes, K. V., & Li, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104306108 · Cited by 200
Global research trends of World Health Organization’s top eight emerging pathogens
Sweileh, W. M. (2017) · Globalization and Health · doi:10.1186/s12992-017-0233-9 · Cited by 200
Viral Respiratory Pathogens and Lung Injury
Clementi, N., Ghosh, S., Santis, M. D., Castelli, M., Criscuolo, E., Zanoni, I., Clementi, M., & Mancini, N. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-20 · Cited by 202
COVID-19 and the Digestive System
Ma, C., Cong, Y., & Zhang, H. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000691 · Cited by 199
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
Ortiz, M. E., Thurman, A. L., Pezzulo, A. A., Leidinger, M., Klesney‐Tait, J., Karp, P. H., Tan, P., Wohlford-Lenane, C., McCray, P. B., & Meyerholz, D. K. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102976 · Cited by 199
Emodin inhibits current through SARS-associated coronavirus 3a protein
Schwarz, S., Wang, K., Yu, W., Sun, B., & Schwarz, W. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.02.008 · Cited by 198
A review of vaccine research and development: Human acute respiratory infections
Girard, M. P., Cherian, T., Pervikov, Y., & Kiény, M. P. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.046 · Cited by 198
Golden, J. W., Cline, C. R., Zeng, X., Garrison, A. R., Carey, B. D., Mucker, E. M., White, L. E., Shamblin, J. D., Brocato, R. L., Liu, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142032 · Cited by 200
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
Yang, Q., Hughes, T. A., Kelkar, A., Yu, X., Cheng, K., Park, S., Huang, W., Lovell, J. F., & Neelamegham, S. (2020) · eLife · doi:10.7554/elife.61552 · Cited by 199
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis
Yang, X., Jin, Y., Li, R., Zhang, Z., Sun, R., & Chen, D. (2020) · Critical Care · doi:10.1186/s13054-020-03065-4 · Cited by 197
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, J., Tao, H., Yan, Y., Huang, S., & Xiao, Y. (2020) · Viruses · doi:10.3390/v12040428 · Cited by 196
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
Rathnasinghe, R., Strohmeier, S., Amanat, F., Gillespie, V., Krammer, F., García‐Sastre, A., Coughlan, L., Schotsaert, M., & Uccellini, M. B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1838955 · Cited by 198
One year update on the COVID-19 pandemic: Where are we now?
Mishra, S. K., & Tripathi, T. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105778 · Cited by 196
Hwang, W. C., Lin, Y., Santelli, E., Sui, J., Jaroszewski, L., Stec, B., Farzan, M., Marasco, W. A., & Liddington, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603275200 · Cited by 195
Self-citationLee, J.-H., Choi, M., Jung, Y., Lee, S. K., Lee, C., Kim, J., Kim, J.-W., Kim, N. H., Kim, B., & Kim, H. G. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112715 · Cited by 195
New onset diabetes, type 1 diabetes and COVID-19
Boddu, S. K., Aurangabadkar, G., & Kuchay, M. S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.012 · Cited by 195
Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Lee, B., Kang, I., & Yu, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040711 · Cited by 195
Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection
Møller-Tank, S., & Maury, W. J. (2014) · Virology · doi:10.1016/j.virol.2014.09.009 · Cited by 192
Ren, X., Glende, J., Alfalah, M., de Vries, V., Schwegmann‐Weßels, C., Qu, X., Tan, L., Tschernig, T., Deng, H., Naim, H. Y., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81749-0 · Cited by 192
Entry of Human Coronavirus NL63 into the Cell
Milewska, A., Nowak, P., Owczarek, K., Szczepański, A., Zarębski, M., Hoang, A., Berniak, K., Wojarski, J., Żegleń, S., Baster, Z., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01933-17 · Cited by 192
Xiao, L., Sakagami, H., & Miwa, N. (2020) · Viruses · doi:10.3390/v12050491 · Cited by 193
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Rajah, M. M., Hubert, M., Bishop, E., Saunders, N., Robinot, R., Grzelak, L., Planas, D., Dufloo, J., Gellenoncourt, S., Bongers, A., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108944 · Cited by 192
Pathogenetic mechanisms of severe acute respiratory syndrome
Guo, Y. X., Korteweg, C., McNutt, M. A., & Gu, J. (2007) · Virus Research · doi:10.1016/j.virusres.2007.01.022 · Cited by 192
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Wang, M., Lam, C. S. F., Xu, H., Guo, R., Chan, K., Zheng, B., et al. (2007) · Virology · doi:10.1016/j.virol.2007.06.009 · Cited by 191
Li, W., Sui, J., Huang, I., Kuhn, J. H., Radoshitzky, S. R., Marasco, W. A., Choe, H., & Farzan, M. (2007) · Virology · doi:10.1016/j.virol.2007.04.035 · Cited by 191
Self-citationArgyropoulos, K. V., Serrano, A., Hu, J., Black, M. A., Feng, X., Shen, G., Call, M., Kim, M. J., Lytle, A. G., Belovarac, B., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.07.001 · Cited by 191
RetractedDual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Mehdipour, A. R., & Hummer, G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100425118 · Cited by 191
Markers and Biomarkers of Endothelium: When Something Is Rotten in the State
Goncharov, N. V., Nadeev, A. D., Jenkins, R. O., & Avdonin, P. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9759735 · Cited by 190
Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
Gembardt, F., Sterner‐Kock, A., Imboden, H., Spalteholz, M., Reibitz, F., Schultheiß, H., Siems, W., & Walther, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.009 · Cited by 190
Carvalho, A., Alqusairi, R., Adams, A., Paul, M., Kothari, N. J., Peters, S. L., & DeBenedet, A. T. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000667 · Cited by 190
Fu, J., Zhou, B., Zhang, L., Balaji, K. S., Wei, C., Liu, X., Chen, H., Peng, J., & Fu, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05478-4 · Cited by 190
Mackman, N., Antoniak, S., Wolberg, A. S., Kasthuri, R. S., & Key, N. S. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314514 · Cited by 190
Boozari, M., & Hosseinzadeh, H. (2020) · Phytotherapy Research · doi:10.1002/ptr.6873 · Cited by 190
Madjunkov, M., Dviri, M., & Librach, C. L. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00737-1 · Cited by 190
Apelin is a positive regulator of ACE2 in failing hearts
Sato, T., SUZUKI, T. A., Watanabe, H., Kadowaki, A., Fukamizu, A., Liu, P. P., Kimura, A., Ito, H., Penninger, J. M., Imai, Y., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69608 · Cited by 189
Sáinz, B., Mossel, E. C., Peters, C. J., & Garry, R. F. (2004) · Virology · doi:10.1016/j.virol.2004.08.011 · Cited by 188
Chu, H., Chan, C.-M., Zhang, X., Wang, Y., Yuan, S., Zhou, J., Au-Yeung, R. K. H., Sze, K. H., Yang, D., Shuai, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001897 · Cited by 188
Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
Lazartigues, E. D., Qadir, M. M. F., & Mauvais‐Jarvis, F. (2020) · Endocrinology · doi:10.1210/endocr/bqaa108 · Cited by 188
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein
Šanda, M., Morrison, L. J., & Goldman, R. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03173 · Cited by 188
Leng, A., Shah, M. M., Ahmad, S. A., Premraj, L., Wildi, K. S., Bassi, G. L., Pardo, C. A., Choi, A., & Cho, S. (2023) · Cells · doi:10.3390/cells12050816 · Cited by 188
SARS-coronavirus replication in human peripheral monocytes/macrophages
Yilla, M., Harcourt, B. H., Hickman, C. J., McGrew, M., Tamin, A., Goldsmith, C. S., Bellini, W. J., & Anderson, L. J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.09.004 · Cited by 187
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
Bernard, I., Limonta, D., Mahal, L. K., & Hobman, T. C. (2020) · Viruses · doi:10.3390/v13010029 · Cited by 187
COVID-19: Knowns, Unknowns, and Questions
Weston, S. M., & Frieman, M. B. (2020) · mSphere · doi:10.1128/msphere.00203-20 · Cited by 187
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor
Huentelman, M. J., Zubcevic, J. A., Prada, J. A. H., Xiao, X., Dimitrov, D. S., Raizada, M. K., & Ostrov, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000146120.29648.36 · Cited by 186
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Kotfis, K., Ghavami, S., & Łoś, M. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100719 · Cited by 186
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction
Ejemel, M., Li, Q., Hou, S., Schiller, Z. A., Tree, J. A., Wallace, A., Amcheslavsky, A., Yılmaz, N. K., Buttigieg, K. R., Elmore, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18058-8 · Cited by 185
Blume, C., Jackson, C. L., Spalluto, C. M., Legebeke, J., Nazlamova, L., Conforti, F., Perotin, J., Frank, M., Butler, J., Crispin, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00759-x · Cited by 187
Animal models for SARS and MERS coronaviruses
Gretebeck, L., & Subbarao, K. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.009 · Cited by 185
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Yang, H., Bartlam, M. G., & Rao, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010369 · Cited by 184
Li, G., Li, Y., Yamate, M., Li, S., & Ikuta, K. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.10.015 · Cited by 184
Li, F. (2008) · Journal of Virology · doi:10.1128/jvi.00442-08 · Cited by 184
Albarello, F., Pianura, E., Stefano, F. D., Cristofaro, M., Petrone, A., Marchioni, L., Palazzolo, C., Schininà, V., Nicastri, E., Petrosillo, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.043 · Cited by 184
Mohanty, S. K., Satapathy, A., Naidu, M. M., Mukhopadhyay, S., Sharma, S., Barton, L. M., Stroberg, E., Duval, E. J., Pradhan, D., Tzankov, A., et al. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-01017-8 · Cited by 185
Roper, R. L., & Rehm, K. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.43 · Cited by 183
Li, X., Molina‐Molina, M., Abdul‐Hafez, A., Uhal, V., Xaubet, A., & Uhal, B. D. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2008 · Cited by 183
Davidson, A. M., Wysocki, J. A., & BATLLE, D. C. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15256 · Cited by 183
Warner, F. J., Lew, R. A., Smith, A. I., Lambert, D., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508914200 · Cited by 182
Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
Ramos, I., Stamatakis, K., Oeste, C. L., & Pérez‐Sala, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134675 · Cited by 182
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., Tian, H., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 181
Self-citationHematological findings in coronavirus disease 2019: indications of progression of disease
Liu, X., Zhang, R., & He, G. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04103-5 · Cited by 182
Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
Moreau, G. B., Burgess, S. L., Sturek, J. M., Donlan, A. N., Petri, W. A., & Mann, B. J. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0762 · Cited by 181
Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., Lin, X., Poon, V. K., Sun, T., Lau, C. C.-Y., Chan, J. F., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 180
Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B., Jiang, S., & Zhou, Y. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 180
Aguiar, J. A., Tremblay, B. J.-M., Mansfield, M. J., Woody, O. Z., Lobb, B., Banerjee, A., Chandiramohan, A., Tiessen, N., Cao, Q., Dvorkin‐Gheva, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01123-2020 · Cited by 180
History of the COVID-19 pandemic: Origin, explosion, worldwide spreading
Platto, S., Wang, Y., Zhou, J., & Carafoli, E. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.087 · Cited by 180
Review of indoor aerosol generation, transport, and control in the context of COVID‐19
Kohanski, M. A., Lo, L. J., & Waring, M. S. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22661 · Cited by 180
Potential Factors Influencing Repeated SARS Outbreaks in China
Sun, Z., Thilakavathy, K., Kumar, S. S., He, G., & Liu, S. V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051633 · Cited by 178
Zhao, X., Jiang, Y., Zhao, Y., Xi, H., Liu, C., Qu, F., & Feng, X. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03897-6 · Cited by 178
The role of high cholesterol in SARS-CoV-2 infectivity
Wang, H., Yuan, Z., Pavel, M. A., Jablonski, S. M., Jablonski, J. A., Hobson, R. J., Valente, S. T., Reddy, C. B., & Hansen, S. B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104763 · Cited by 178
COVID-19 as an Acute Inflammatory Disease
Manjili, R. H., Zarei, M., Habibi, M., & Manjili, M. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000413 · Cited by 178
Prasanth, D., Murahari, M., Chandramohan, V., Panda, S. P., Rao, A. L., & Guntupalli, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779129 · Cited by 178
Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V. K., Lu, L., Wang, L., Debnath, A. K., Zheng, B.-J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01048-13 · Cited by 177
Quan, P., Firth, C., Street, C., Henriquez, J. A., Petrosov, A., Tashmukhamedova, A., Hutchison, S. K., Egholm, M., Osinubi, M. O. V., Niezgoda, M., et al. (2010) · mBio · doi:10.1128/mbio.00208-10 · Cited by 177
McBride, C. E., Li, J., & Machamer, C. E. (2006) · Journal of Virology · doi:10.1128/jvi.02146-06 · Cited by 177
Ratajczak, M. Z., Bujko, K., Ciechanowicz, A. K., Sielatycka, K., Cymer, M., Marlicz, W. M., & Kucia, M. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10010-z · Cited by 175
Sialic acids as receptor determinants for coronaviruses
Schwegmann‐Weßels, C., & Herrler, G. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-5437-9 · Cited by 175
Potential antivirals and antiviral strategies against SARS coronavirus infections
Clercq, E. D. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.291 · Cited by 175
ACE2-independent infection of T lymphocytes by SARS-CoV-2
Shen, X.-R., Geng, R., Li, Q., Chen, Y., Li, S., Wang, Q. M., Min, J., Yang, Y. P., Li, B., Jiang, R.-D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00919-x · Cited by 175
COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics
Azer, S. A. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100738 · Cited by 173
Modeling the viral dynamics of SARS-CoV-2 infection
Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 173
Metadata
- Authors
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Choe, Hyeryun
- Farzan, Michael
- ORCID
- Venue
- Nature
- Published
- 2003-11-27
- Volume
- 426
- Issue
- 6965
- Pages
- 450-454
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095016
- OpenAlex
- W1966238900
- Cited by
- 5,923
- References
- 32
- Citations by year
- 2026: 74 · 2025: 145 · 2024: 298 · 2023: 448 · 2022: 732 · 2021: 1288 · 2020: 1794 · 2019: 32 · 2018: 30 · 2017: 44 · 2016: 50 · 2015: 49 · 2014: 62 · 2013: 43 · 2012: 50
- FWCI
- 79.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Aeronautics and Space Administration
- Hawaii Community Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- angiotensin-converting enzyme 2, SARS coronavirus, viral receptor, receptor binding, syncytium formation, viral replication, ACE1, Vero E6 cells, HEK293T cells, antibody inhibition
- MeSH terms
- Angiotensin-Converting Enzyme 2, Animals, Antibodies, Carboxypeptidases, Cell Line, Chlorocebus aethiops, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Molecular Weight, Protein Binding, Receptors, Virus, Solubility, Transfection, Vero Cells, Viral Envelope Proteins, Virus Replication, Giant Cells, Protein Structure, Tertiary, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
